-
1
-
-
33646472759
-
Ten-year incidence of retinal vein occlusion in an older population: The Blue Mountain Eye study
-
Cugati S, Wang JJ, Rochtchine E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountain Eye study. Arch Ophthalmol. 2006;124:726-732.
-
(2006)
Arch Ophthalmol
, vol.124
, pp. 726-732
-
-
Cugati, S.1
Wang, J.J.2
Rochtchine, E.3
Mitchell, P.4
-
3
-
-
0038388933
-
Retinal vein occlusion and hyperhomocysteinemia
-
Blond J, Glacet-Bernard A, Bayani N, et al. Retinal vein occlusion and hyperhomocysteinemia. J Fr Opthalmol. 2003;26:249-253.
-
(2003)
J Fr Opthalmol
, vol.26
, pp. 249-253
-
-
Blond, J.1
Glacet-Bernard, A.2
Bayani, N.3
-
4
-
-
0026551575
-
Risk factors for retinal vein occlusion. A case-control study
-
Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusion. A case-control study. Ophthalmology. 1992;99:509-514.
-
(1992)
Ophthalmology
, vol.99
, pp. 509-514
-
-
Rath, E.Z.1
Frank, R.N.2
Shin, D.H.3
Kim, C.4
-
5
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
Aiello L P, Avery RL, Arrig PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
-
(1994)
N Engl J Med
, vol.331
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrig, P.G.3
-
6
-
-
0021221946
-
Argon laser photocoagu-lation for macular edema in branch vein occlusion
-
Branch Retinal Vein Occlusion Study Group
-
Branch Retinal Vein Occlusion Study Group. Argon laser photocoagu-lation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-282.
-
(1984)
Am J Ophthalmol
, vol.98
, pp. 271-282
-
-
-
7
-
-
23044440795
-
Optical cohorence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusion
-
Rosenfeld PJ, Fung AE, Puliafto CA. Optical cohorence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
-
(2005)
Ophthalmic Surg Lasers Imaging
, vol.36
, pp. 336-339
-
-
Rosenfeld, P.J.1
Fung, A.E.2
Puliafto, C.A.3
-
8
-
-
26844431631
-
Intravitreal triamcinolone compared with macular grid photocoagulation for the treatment of cystoid macular edema
-
Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol. 2005;140:695-702.
-
(2005)
Am J Ophthalmol
, vol.140
, pp. 695-702
-
-
Avitabile, T.1
Longo, A.2
Reibaldi, A.3
-
9
-
-
37349021336
-
Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central vein occlusion
-
Karacorlu M, Karacorlu SA, Ozdemir H, et al. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central vein occlusion. Retina. 2007;27:1026-1030.
-
(2007)
Retina
, vol.27
, pp. 1026-1030
-
-
Karacorlu, M.1
Karacorlu, S.A.2
Ozdemir, H.3
-
10
-
-
33749602030
-
One-year safety and efficacy of intravitreal triamcinolone acetonide for the managment of macular edema secondary to central vein occlusion
-
Gregori NZ, Rosenfeld PJ, Puliafto CA, et al. One-year safety and efficacy of intravitreal triamcinolone acetonide for the managment of macular edema secondary to central vein occlusion. Retina. 2006;26: 889-895.
-
(2006)
Retina
, vol.26
, pp. 889-895
-
-
Gregori, N.Z.1
Rosenfeld, P.J.2
Puliafto, C.A.3
-
11
-
-
64849111444
-
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of prospective clinical trial
-
Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of prospective clinical trial. Br J Ophthalmol. 2009; 93:452-456.
-
(2009)
Br J Ophthalmol
, vol.93
, pp. 452-456
-
-
Prager, F.1
Michels, S.2
Kriechbaum, K.3
-
12
-
-
66249083148
-
The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion
-
Ahmadi AA, Chuo J Y, Banashkevich A, et al. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion. Can J Ophthalmol. 2009;44:154-159.
-
(2009)
Can J Ophthalmol
, vol.44
, pp. 154-159
-
-
Ahmadi, A.A.1
Chuo, J.Y.2
Banashkevich, A.3
-
13
-
-
77949899274
-
Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion
-
Kim J Y, Park S P. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol. 2009;23:259-265.
-
(2009)
Korean J Ophthalmol
, vol.23
, pp. 259-265
-
-
Kim, J.Y.1
Park, S.P.2
-
14
-
-
73449130129
-
Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: A matched study
-
Hou J, Tao Y, Jiang YR, et al. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study. Chin Med J (Eng). 2009;122:2695-2699.
-
(2009)
Chin Med J (Eng)
, vol.122
, pp. 2695-2699
-
-
Hou, J.1
Tao, Y.2
Jiang, Y.R.3
-
15
-
-
33646446084
-
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study
-
Iturradle CB, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26:279-284.
-
(2006)
Retina
, vol.26
, pp. 279-284
-
-
Iturradle, C.B.1
Spaide, R.F.2
Meyerle, C.B.3
-
16
-
-
37349040676
-
Intravitreal bevacizuma (Avastin) in central vein occlusion
-
Hsu J, Kaiser RS, Sivalingam A, et al. Intravitreal bevacizuma (Avastin) in central vein occlusion. Retina. 2007;27:1013-1019.
-
(2007)
Retina
, vol.27
, pp. 1013-1019
-
-
Hsu, J.1
Kaiser, R.S.2
Sivalingam, A.3
-
17
-
-
34247231034
-
Intravitreal bevaci-zumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
-
Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevaci-zumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419-425.
-
(2007)
Retina
, vol.27
, pp. 419-425
-
-
Rabena, M.D.1
Pieramici, D.J.2
Castellarin, A.A.3
-
18
-
-
53849117478
-
Treatment of branch retinal vein occlusion induced macular edema with bevacizumab
-
Abegg M, Tappeiner C, Wolf-Schnurrbush U, et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol. 2008;8:18.
-
(2008)
BMC Ophthalmol
, vol.8
, pp. 18
-
-
Abegg, M.1
Tappeiner, C.2
Wolf-Schnurrbush, U.3
-
19
-
-
77955243577
-
Results of bevacizumab as the primary treatment for retinal vein occlusions
-
Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol. 2010;94:1052-1056.
-
(2010)
Br J Ophthalmol
, vol.94
, pp. 1052-1056
-
-
Figueroa, M.S.1
Contreras, I.2
Noval, S.3
Arruabarrena, C.4
-
20
-
-
77951240776
-
Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in pair-matched analysis
-
Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in pair-matched analysis. Ophthalmologica. 2010;224:319-324.
-
(2010)
Ophthalmologica
, vol.224
, pp. 319-324
-
-
Guthoff, R.1
Meigen, T.2
Hennemann, K.3
Schrader, W.4
-
21
-
-
73349118494
-
Comparison of two doses intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American Collaborative Retina Study Group at 24 months
-
Wu L, Arevalo JF, Berrocai MH, et al. Comparison of two doses intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Retina. 2009;29: 1396-1403.
-
(2009)
Retina
, vol.29
, pp. 1396-1403
-
-
Wu, L.1
Arevalo, J.F.2
Berrocai, M.H.3
-
22
-
-
71449106064
-
Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion
-
Ach T, Hoeh AE, Schaal KB, et al. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:1635-1641.
-
(2009)
Graefes Arch Clin Exp Ophthalmol
, vol.247
, pp. 1635-1641
-
-
Ach, T.1
Hoeh, A.E.2
Schaal, K.B.3
-
23
-
-
33750296920
-
The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
-
Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006;90:1344-1349.
-
(2006)
Br J Ophthalmol
, vol.90
, pp. 1344-1349
-
-
Fung, A.E.1
Rosenfeld, P.J.2
Reichel, E.3
-
24
-
-
77957554417
-
Bevacizumab compared with macular laser grid photocoagulation for cystiod macular edema in branch retinal vein occlusion
-
Russo V, Barone A, Conte E, et al. Bevacizumab compared with macular laser grid photocoagulation for cystiod macular edema in branch retinal vein occlusion. Retina. 2010;30:1324-1325.
-
(2010)
Retina
, vol.30
, pp. 1324-1325
-
-
Russo, V.1
Barone, A.2
Conte, E.3
-
25
-
-
77957039719
-
A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion
-
Cekic O, Cakir M, Yazici AT, et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res. 2010;35:925-929.
-
(2010)
Curr Eye Res
, vol.35
, pp. 925-929
-
-
Cekic, O.1
Cakir, M.2
Yazici, A.T.3
-
26
-
-
77955390110
-
Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone
-
Rezende M P, Dias AF, Oshima A, et al. Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone. Arq Bras Oftalmol. 2010;73:129-134.
-
(2010)
Arq Bras Oftalmol
, vol.73
, pp. 129-134
-
-
Rezende, M.P.1
Dias, A.F.2
Oshima, A.3
-
27
-
-
42549132257
-
Secondary ocular hypertension after intravitreal injection of 4 mg of triam-cinolone acetonide: Incidence and risk factors
-
Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB. Secondary ocular hypertension after intravitreal injection of 4 mg of triam-cinolone acetonide: incidence and risk factors. Retina. 2008;28:573-580.
-
(2008)
Retina
, vol.28
, pp. 573-580
-
-
Vasconcelos-Santos, D.V.1
Nehemy, P.G.2
Schachat, A.P.3
Nehemy, M.B.4
-
28
-
-
77955346303
-
Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective date from a randomised clinical trial
-
Gillies MC, Islam FM, Larsson J, et al. Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective date from a randomised clinical trial. Clin Experiment Ophthalmol. 2010;38: 605-612.
-
(2010)
Clin Experiment Ophthalmol
, vol.38
, pp. 605-612
-
-
Gillies, M.C.1
Islam, F.M.2
Larsson, J.3
-
29
-
-
33847637137
-
Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years
-
Islam MS, Vernon SA, Negi A. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years. Eye (Lond). 2007;21:321-323.
-
(2007)
Eye (Lond)
, vol.21
, pp. 321-323
-
-
Islam, M.S.1
Vernon, S.A.2
Negi, A.3
-
30
-
-
38349179299
-
Aqueous humour of cytocines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion
-
Noma H, Funatsu H, Yamasaki, et al. Aqueous humour of cytocines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond). 2008;22:42-48.
-
(2008)
Eye (Lond)
, vol.22
, pp. 42-48
-
-
Noma, H.1
Funatsu, H.2
Yamasaki3
-
31
-
-
33646256581
-
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion
-
Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Exp Ophthalmol. 2006;244:309-315.
-
(2006)
Graefes Arch Exp Ophthalmol
, vol.244
, pp. 309-315
-
-
Noma, H.1
Minamoto, A.2
Funatsu, H.3
|